KR8803 Successfully Registered With The German Healthcare System
2026/04/27
As a benchmark country for rehabilitation medicine in Europe, Germany has extremely stringent standards for assistive device protection and safety for people with mobility impairments. With Germany's aging population and steadily increasing demand for rehabilitation medicine, local medical institutions, nursing homes, and families are placing higher demands on the safety, durability, and compliance of electric wheelchairs , meeting market requirements that align with EU MDR regulations . Against this backdrop, our KR8803 electric wheelchair underwent rigorous SGS testing and successfully passed the EU CE MDR certification . It also gained favor with German customers, who used our product as the core to complete the registration with the German Federal Agency for Medicines and Health Products (BfArM), officially incorporating it into the German healthcare system and obtaining legal access qualifications in medical institutions, rehabilitation centers, and health insurance coverage scenarios throughout Germany.
The KR8803 is specifically designed for European user habits and road conditions, with key advantages: Featuring a high-strength, lightweight frame , it balances structural stability with agile handling, making it suitable for both narrow indoor spaces and outdoor ramps. Equipped with silent dual drive motors and intelligent electromagnetic brakes , it provides stable parking on slopes and a smooth and safe ride. Equipped with a high-resilience, pressure-relieving seat and adjustable armrests , it reduces fatigue during long journeys and meets ergonomic and German care standards. Includes German-language instructions and labels, meeting the localization compliance requirements of the German healthcare system. This successful registration signifies that KR8803 fully complies with the German Medical Devices Act (MPG) and the EU MDR regulatory requirements, and can be included in the German public medical procurement catalog and rehabilitation institution tender list. It also supports eligible users to apply for reimbursement through German statutory health insurance and commercial insurance. The successful entry of KR8803 into the German healthcare system is not only an international recognition of the product's quality and technological strength by authoritative regulators, but also provides German people with mobility impairments with a cost-effective and reliable travel solution. This helps "Made in China" rehabilitation aids to penetrate the high-end European market and bring a safer and more comfortable independent travel experience to users worldwide.